RESEARCH NOTICE & LEGAL DISCLAIMER
FOR RESEARCH PURPOSES ONLY. All information provided within the Biolabs Peptides Research Centre is intended strictly for scientific, laboratory, and educational purposes.
-
Not Medical Advice: The protocols and data presented herein do not constitute medical advice, nursing advice, or a professional healthcare diagnosis.
-
Non-Therapeutic: These peptides are not intended to diagnose, treat, cure, or prevent any medical condition or disease.
-
Researcher Responsibility: Any research conducted should be performed by qualified professionals in a controlled laboratory environment. By accessing this data, you acknowledge that you are responsible for following your local laws and institutional safety guidelines.
HIGHLIGHTS
SS-31 (Elamipretide) is a groundbreaking, mitochondria-targeted tetrapeptide. It is uniquely engineered to penetrate cell membranes and selectively bind to cardiolipin within the inner mitochondrial membrane. In research settings, it is studied for its ability to stabilize mitochondrial structure, boost ATP (energy) production, and significantly reduce oxidative stress. This Biolabs Peptides protocol provides a framework for investigating its protective effects on metabolically demanding tissues like the heart, brain, and skeletal muscle.
SS-31 (Elamipretide) 50 mg Vial: Dosage Protocol
SS-31 is a mitochondrial-targeted peptide utilized in research for cellular energy and oxidative stress management. Unlike metabolic peptides, SS-31 is generally administered in consistent daily doses.
1. Reconstitution (Mixing)
-
Diluent: Add 3.0 mL of Bacteriostatic Water to your 50 mg vial.
-
Concentration: This creates a 16.67 mg/mL solution.
-
Measurement: On a standard U-100 (1 mL) insulin syringe:
-
6 Units = 1.0 mg
-
15 Units = 2.5 mg
-
30 Units = 5.0 mg
-
60 Units = 10.0 mg
-
2. Dosing Schedule
(Doses are administered via subcutaneous injection)
Option A: Standard Daily Protocol
-
Daily Dose: 10 mg
-
Syringe Volume: 60 Units
-
Duration: Commonly researched in cycles of 20 to 30 days.
Option B: Low-Dose Maintenance
-
Daily Dose: 5 mg
-
Syringe Volume: 30 Units
-
Duration: Used for extended mitochondrial support.
3. Administration & Storage
-
Method: Subcutaneous injection into the abdomen, thigh, or upper arm. Rotate injection sites daily.
-
Frequency: Administered once daily, preferably at the same time each day.
-
Storage: Keep unopened vials in the freezer. Once reconstituted (mixed), store in the refrigerator and use within 28 days for maximum stability.
4. Considerations
-
Protocol Logic: SS-31 is researched for its ability to stabilize cardiolipin within the mitochondria.
-
Side Effects: While generally well-tolerated in research settings, some may experience mild redness or irritation at the injection site.
-
Hydration: Maintaining adequate hydration is recommended to support cellular detoxification during the cycle.
SAHPRA COMPLIANCE & LEGAL DISCLAIMER
ATTENTION: This product is NOT REGISTERED with the South African Health Products Regulatory Authority (SAHPRA).
-
This medicine has not been evaluated by SAHPRA for its quality, safety, or intended use.
-
SS-31 (Elamipretide) is currently an investigational compound and is not approved for the treatment of any medical condition in South Africa.
-
In terms of the Medicines and Related Substances Act (Act 101 of 1965), the use of unregistered medicines is generally restricted to authorized clinical trials or specific Section 21 authorizations.
-
WARNING: Compounded or unregistered peptides have been flagged by SAHPRA as potentially "undesirable" due to risks of contamination, incorrect dosing, and lack of sterile oversight. Use of this substance is at the user’s own risk. Consult a registered medical practitioner before use.
Medical Notice: This document is for informational purposes only and does not replace professional medical advice. If you experience any adverse reactions, discontinue use and seek immediate medical attention.